Marinus Pharmaceuticals to Present At Credit Suisse Healthcare Conference
RADNOR, Pa., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that …